• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和性别交叉的重要性,以了解原发性恶性脑肿瘤发病率和生存率的变化。

Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.

机构信息

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

出版信息

Neuro Oncol. 2022 Feb 1;24(2):302-310. doi: 10.1093/neuonc/noab199.

DOI:10.1093/neuonc/noab199
PMID:34387331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8804884/
Abstract

BACKGROUND

Gliomas are the most common type of malignant brain and other CNS tumors, accounting for 80.8% of malignant primary brain and CNS tumors. They cause significant morbidity and mortality. This study investigates the intersection between age and sex to better understand variation of incidence and survival for glioma in the United States.

METHODS

Incidence data from 2000 to 2017 were obtained from CBTRUS, which obtains data from the NPCR and SEER, and survival data from the CDC's NPCR. Age-adjusted incidence rate ratios (IRR) per 100 000 were generated to compare male-to-female incidence by age group. Cox proportional hazard models were performed by age group, generating hazard ratios to assess male-to-female survival differences.

RESULTS

Overall, glioma incidence was higher in males. Male-to-female incidence was lowest in ages 0-9 years (IRR: 1.04, 95% CI: 1.01-1.07, P = .003), increasing with age, peaking at 50-59 years (IRR: 1.56, 95% CI: 1.53-1.59, P < .001). Females had worse survival for ages 0-9 (HR: 0.93, 95% CI: 0.87-0.99), though male survival was worse for all other age groups, with the difference highest in those 20-29 years (HR: 1.36, 95% CI: 1.28-1.44). Incidence and survival differences by age and sex also varied by histological subtype of glioma.

CONCLUSIONS

To better understand the variation in glioma incidence and survival, investigating the intersection of age and sex is key. The current work shows that the combined impact of these variables is dependent on glioma subtype. These results contribute to the growing understanding of sex and age differences that impact cancer incidence and survival.

摘要

背景

神经胶质瘤是最常见的恶性脑和中枢神经系统肿瘤,占恶性原发性脑和中枢神经系统肿瘤的 80.8%。它们导致了高发病率和死亡率。本研究通过研究年龄和性别之间的关系,以更好地了解美国神经胶质瘤的发病和生存情况的变化。

方法

从 CBTRUS 获取 2000 年至 2017 年的发病率数据,该组织从 NPCR 和 SEER 中获取数据,从疾病预防控制中心的 NPCR 中获取生存率数据。通过年龄组生成每 100000 人年龄调整发病率比(IRR),以比较男性与女性的发病率。通过年龄组进行 Cox 比例风险模型,生成风险比以评估男性与女性的生存差异。

结果

总体而言,男性神经胶质瘤的发病率较高。男性与女性的发病率在 0-9 岁年龄组最低(IRR:1.04,95%CI:1.01-1.07,P =.003),随着年龄的增长而增加,在 50-59 岁年龄组达到峰值(IRR:1.56,95%CI:1.53-1.59,P <.001)。对于 0-9 岁年龄组的女性,生存率较差(HR:0.93,95%CI:0.87-0.99),而对于所有其他年龄组的男性,生存率较差,在 20-29 岁年龄组差异最高(HR:1.36,95%CI:1.28-1.44)。按年龄和性别划分的发病率和生存率差异也因神经胶质瘤的组织学亚型而异。

结论

为了更好地了解神经胶质瘤发病率和生存率的变化,研究年龄和性别的交叉点是关键。目前的研究表明,这些变量的综合影响取决于神经胶质瘤的亚型。这些结果有助于加深对影响癌症发病率和生存率的性别和年龄差异的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/3ad568e59467/noab199f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/f4a549593acc/noab199f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/858b78e81659/noab199f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/3ad568e59467/noab199f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/f4a549593acc/noab199f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/858b78e81659/noab199f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2027/8804884/3ad568e59467/noab199f0003.jpg

相似文献

1
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.年龄和性别交叉的重要性,以了解原发性恶性脑肿瘤发病率和生存率的变化。
Neuro Oncol. 2022 Feb 1;24(2):302-310. doi: 10.1093/neuonc/noab199.
2
Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study.原发性脊髓恶性胶质瘤的发病模式:监测、流行病学和最终结果研究。
J Neurosurg Spine. 2011 Jun;14(6):742-7. doi: 10.3171/2011.1.SPINE10351. Epub 2011 Mar 11.
3
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.CBTRUS 统计报告:美国脑肿瘤协会和 NCI 神经肿瘤学分部 2016-2020 年在美国诊断的青少年和年轻成人原发性脑和其他中枢神经系统肿瘤。
Neuro Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi: 10.1093/neuonc/noae047.
4
Brain and other central nervous system tumor statistics, 2021.脑和其他中枢神经系统肿瘤统计,2021 年。
CA Cancer J Clin. 2021 Sep;71(5):381-406. doi: 10.3322/caac.21693. Epub 2021 Aug 24.
5
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021.美国 2017-2021 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2024 Oct 6;26(Supplement_6):vi1-vi85. doi: 10.1093/neuonc/noae145.
6
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.确定 12 种选定的罕见中枢神经系统肿瘤影响的合作伙伴关系:来自 CBTRUS 和 NCI-CONNECT 的报告。
J Neurooncol. 2019 Aug;144(1):53-63. doi: 10.1007/s11060-019-03215-x. Epub 2019 Jun 17.
7
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.2001 年至 2013 年美国髓母细胞瘤的发病率和生存趋势。
J Neurooncol. 2017 Dec;135(3):433-441. doi: 10.1007/s11060-017-2594-6. Epub 2017 Aug 21.
8
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.描述性流行病学:美国 2006 年至 2015 年期间诊断的中枢神经系统生殖细胞肿瘤。
J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.
9
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.美国 2015-2019 年确诊的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
10
Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis.中枢神经系统生殖细胞肿瘤的描述性流行病学:松果体外分析。
Neuro Oncol. 2010 Mar;12(3):257-64. doi: 10.1093/neuonc/nop029. Epub 2009 Dec 21.

引用本文的文献

1
The glioma microenvironment and its impact on antitumor immunity.胶质瘤微环境及其对抗肿瘤免疫的影响。
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv19-iv31. doi: 10.1093/noajnl/vdae204. eCollection 2025 Sep.
2
Analysis of epidemiology and nomogram construction for prediction and clinical decision-making in gliomas.胶质瘤的流行病学分析及预测与临床决策列线图构建
Front Immunol. 2025 Aug 1;16:1624142. doi: 10.3389/fimmu.2025.1624142. eCollection 2025.
3
Intersectionality approaches to address health disparities in cancer survivorship care: a systematic scoping review.

本文引用的文献

1
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.美国 2013-2017 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96. doi: 10.1093/neuonc/noaa200.
3
Establishment of age group classification for risk stratification in glioma patients.建立年龄组分类以对胶质瘤患者进行风险分层。
用于解决癌症幸存者护理中健康差异的交叉性方法:一项系统的范围综述。
Support Care Cancer. 2025 Aug 9;33(9):772. doi: 10.1007/s00520-025-09830-x.
4
Integrated clinicopathological-radiomic-blood model for glioma survival prediction via machine learning: a multicenter cohort study.基于机器学习的胶质瘤生存预测综合临床病理-影像组学-血液模型:一项多中心队列研究
Neurosurg Rev. 2025 Jul 12;48(1):560. doi: 10.1007/s10143-025-03719-3.
5
Socioeconomic influences on survival outcome in idh-wildtype glioma patients: examining the role of age, education, and lifestyle factors.社会经济因素对异柠檬酸脱氢酶野生型胶质瘤患者生存结局的影响:探讨年龄、教育程度和生活方式因素的作用。
Acta Neurochir (Wien). 2025 Jun 27;167(1):178. doi: 10.1007/s00701-025-06594-5.
6
Understanding Neovascularization in Glioblastoma: Insights from the Current Literature.了解胶质母细胞瘤中的新生血管形成:来自当前文献的见解。
Int J Mol Sci. 2025 Mar 19;26(6):2763. doi: 10.3390/ijms26062763.
7
A Pan-Cancer Analysis of Age and Sex Differences in Cancer Incidence and Survival in the United States, 2001-2020.2001 - 2020年美国癌症发病率和生存率的年龄与性别差异的全癌分析
Cancers (Basel). 2025 Jan 24;17(3):378. doi: 10.3390/cancers17030378.
8
Long-term epidemiological trends in (primary) pediatric central nervous system tumors: a 25-year cohort analysis in Western Mexico.(原发性)儿童中枢神经系统肿瘤的长期流行病学趋势:墨西哥西部的一项25年队列分析。
Childs Nerv Syst. 2025 Jan 11;41(1):90. doi: 10.1007/s00381-024-06715-y.
9
Epidemiology of malignant brain tumors in Genova, Italy. 1993-2017.意大利热那亚恶性脑肿瘤的流行病学。1993-2017 年。
Sci Rep. 2024 Nov 8;14(1):27300. doi: 10.1038/s41598-024-79170-z.
10
Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for Glioma.基于区域的现有全基因组关联研究分析确定了新的潜在胶质瘤遗传易感区域。
Cancer Res Commun. 2024 Nov 1;4(11):2933-2946. doi: 10.1158/2767-9764.CRC-24-0385.
BMC Neurol. 2020 Aug 20;20(1):310. doi: 10.1186/s12883-020-01888-w.
4
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.胶质瘤根据分子亚型表现出明显的基于性别的差异甲基化模式。
Neurooncol Adv. 2020 Jan 8;2(1):vdaa002. doi: 10.1093/noajnl/vdaa002. eCollection 2020 Jan-Dec.
5
JAM-A functions as a female microglial tumor suppressor in glioblastoma.JAM-A 在胶质母细胞瘤中作为女性小胶质细胞肿瘤抑制因子发挥作用。
Neuro Oncol. 2020 Nov 26;22(11):1591-1601. doi: 10.1093/neuonc/noaa148.
6
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.高龄增加脑内免疫抑制并降低胶质母细胞瘤患者的免疫治疗效果。
Clin Cancer Res. 2020 Oct 1;26(19):5232-5245. doi: 10.1158/1078-0432.CCR-19-3874. Epub 2020 Jun 16.
7
Association between urbanicity and surgical treatment among patients with primary glioblastoma in the United States.美国原发性胶质母细胞瘤患者的城市化程度与手术治疗之间的关联。
Neurooncol Pract. 2020 Jun;7(3):299-305. doi: 10.1093/nop/npaa001. Epub 2020 Jan 8.
8
Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis.癌症发病率和生存率的性别差异:泛癌症分析。
Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1389-1397. doi: 10.1158/1055-9965.EPI-20-0036. Epub 2020 Apr 29.
9
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.髓系来源抑制细胞亚群以性别特异性方式驱动胶质母细胞瘤生长。
Cancer Discov. 2020 Aug;10(8):1210-1225. doi: 10.1158/2159-8290.CD-19-1355. Epub 2020 Apr 16.
10
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma.性别是胶质母细胞瘤的一个重要预后因素,但对非胶质母细胞瘤并非如此。
Neurooncol Pract. 2019 Dec;6(6):451-462. doi: 10.1093/nop/npz019. Epub 2019 May 18.